Impact Factor
3.60
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.52
648 total citations
h5-index
35
h5 depth signal
Cited share
75.3%
149 of 198
Total citations
648
Citation footprint
Metric signal
3.81
External metric anchor
Self-citation
1.5%
10 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
353
United States
123
Italy
108
Iran
95
Brazil
72
Citing Fields of Research
Immunology
924
Musculoskeletal Disorders
128
Auto-Inflammatory Disorders
90
Allergies
86
Hematology
83
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
11,450
Articles tracked across the journal lifetime
Indexed publication set
198
149 cited publications
Last 12 months
115
9.6 publications/month
Open access share
41.7%
48 OA publications in the last year
Leading citing country
China
353 citing publications
Leading citing field
Immunology
924 citing publications
Latest tracked publication
7 October 2026
10 recent records available
Coverage & Indexing History
v3n1,July 1981-
v3n1,July 1981-
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Broad Categories
Allergy and Immunology
Immunology
Musculoskeletal Disorders
Hematology
Allergies
Virology
Inflammatory Bowel Diseases & Infections
MeSH Descriptors
Allergy and Immunology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
03
04
DOI 10.1016/j.imlet.2026.107246
Open DOI
Stromal spatial signatures of the classical adenosine pathway dictate prognosis in hepatocellular carcinoma
05
DOI 10.1016/j.imlet.2026.107245
Open DOI
Involvement of MRGPRX2 signaling in Tween-80-induced pseudo-allergic reactions in mast cells
06
DOI 10.1016/j.imlet.2026.107244
Open DOI
Targeting Mcl-1 to restore IL-10-driven Breg suppression reverses allergic asthma
07
DOI 10.1016/j.imlet.2026.107242
Open DOI
A severely affected MRL/Lpr mouse exhibits a divergent clinical–immune profile associated with profound metabolic alteration
08
DOI 10.1016/j.imlet.2026.107241
Open DOI
Peripheral CHOP+ CD4+ T-cell subsets are reduced and clinically relevant in primary Sjögren’s syndrome
09
DOI 10.1016/j.imlet.2026.107240
Open DOI
Expression and clinical characteristics of CD161 in primary biliary cholangitis
10
Bibliographical & Catalog Notes
Also available online.
Vol. 20, no. 3 (FEB 1989)19900917 Notice published Printed on acid-free paper